Citation: A. Malmberg et al., AGONIST AND INVERSE AGONIST ACTIVITY AT THE DOPAMINE D-3 RECEPTOR MEASURED BY GUANOSINE 5'-[GAMMA-THIO]TRIPHOSPHATE-[S-35] BINDING, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 119-126
Citation: E. Jerning et al., RECEPTOR-BINDING CHARACTERISTICS OF [H-3]NAD-299, A NEW SELECTIVE 5-HT1A RECEPTOR ANTAGONIST, European journal of pharmacology, 360(2-3), 1998, pp. 219-225
Authors:
MALMBERG A
MOHELL N
HOOK BB
JOHANSSON AM
HACKSELL U
NORDVALL G
Citation: A. Malmberg et al., INTERACTIONS OF LIGANDS WITH ACTIVE AND INACTIVE CONFORMATIONS OF THEDOPAMINE D-2 RECEPTOR, European journal of pharmacology, 346(2-3), 1998, pp. 299-307
Authors:
JOHANSSON L
SOHN D
THORBERG SO
JACKSON DM
KELDER D
LARSSON LG
RENYI L
ROSS SB
WALLSTEN C
ERIKSSON H
HU PS
JERNING E
MOHELL N
WESTLINDDANIELSSON A
Citation: L. Johansson et al., THE PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL SELECTIVE 5-HYDROXYTRYPTAMINE(1A) RECEPTOR ANTAGONIST, NAD-299, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 216-225
Citation: Mj. Hansard et al., THE UNUSUAL ACTIONS OF D-LSD AND OTHER ERGOLINE DERIVATIVES AT RAT 5-HT6 RECEPTORS STABLY EXPRESSED IN CHINESE-HAMSTER OVARY (CHO) CELL-LINE, British Journal of Pharmacology, 120, 1997, pp. 120-120
Citation: U. Appelberg et al., DERIVATIVES OF 2-ARYLCYCLOPROPYLAMINE - SYNTHESIS AND INTERACTIONS WITH 5-HT1A RECEPTORS, Bioorganic & medicinal chemistry letters, 6(4), 1996, pp. 415-420
Authors:
HOOK BB
CORTIZO L
JOHANSSON AM
WESTLINDDANIELSSON A
MOHELL N
HACKSELL U
Citation: Bb. Hook et al., DERIVATIVES OF (R)-5-FLUORO-8-HYDROXY-2-(DIPROPYLAMINO)TETRALIN AND (S)-5-FLUORO-8-HYDROXY-2-(DIPROPYLAMINO)TETRALIN - SYNTHESIS AND INTERACTIONS WITH 5-HT1A RECEPTORS, Journal of medicinal chemistry, 39(20), 1996, pp. 4036-4043
Authors:
YU H
LIU Y
MALMBERG A
MOHELL N
HACKSELL U
LEWANDER T
Citation: H. Yu et al., DIFFERENTIAL SEROTONINERGIC AND DOPAMINERGIC ACTIVITIES OF THE (R)-ENANTIOMER AND THE (S)-ENANTIOMER OF 2-(DI-N-PROPYLAMINO) TETRALIN, European journal of pharmacology, 303(3), 1996, pp. 151-162
Citation: A. Malmberg et al., CRITICAL REEVALUATION OF SPIPERONE AND BENZAMIDE BINDING TO DOPAMINE D-2 RECEPTORS - EVIDENCE FOR IDENTICAL BINDING-SITES, European journal of pharmacology, 303(1-2), 1996, pp. 123-128
Citation: E. Jerning et al., IN-VITRO RECEPTOR-BINDING CHARACTERISTICS OF THE NEW DOPAMINE D-2 ANTAGONIST [I-125] NCQ-298 - METHODOLOGICAL CONSIDERATIONS OF HIGH-AFFINITY BINDING, Journal of receptor and signal transduction research, 15(1-4), 1995, pp. 503-515
Citation: U. Hacksell et al., DOES THE DOPAMINE-RECEPTOR SUBTYPE SELECTIVITY OF ANTIPSYCHOTIC AGENTS PROVIDE USEFUL LEADS FOR THE DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS, Pharmacology & toxicology, 76(5), 1995, pp. 320-324
Authors:
HALLDIN C
FARDE L
HOGBERG T
MOHELL N
HALL H
SUHARA T
KARLSSON P
NAKASHIMA Y
SWAHN CG
Citation: C. Halldin et al., CARBON-11-FLB-457 - A RADIOLIGAND FOR EXTRASTRIATAL D2 DOPAMINE-RECEPTORS, The Journal of nuclear medicine, 36(7), 1995, pp. 1275-1281
Authors:
MOHELL N
GEORGIEV J
LARSSON LG
JACKSON DM
BENGTSSON A
MAGNUSSON O
ROSS SB
Citation: N. Mohell et al., TIME-COURSE OF BROMOCRIPTINE INDUCED EXCITATION IN THE RAT - BEHAVIORAL AND BIOCHEMICAL-STUDIES, Naunyn-Schmiedeberg's archives of pharmacology, 351(2), 1995, pp. 146-155
Citation: A. Malmberg et N. Mohell, CHARACTERIZATION OF [H-3] QUINPIROLE BINDING TO HUMAN DOPAMINE D-2A AND D-3 RECEPTORS - EFFECTS OF IONS AND GUANINE-NUCLEOTIDES, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 790-797
Authors:
LIU Y
YU H
MOHELL N
NORDVALL G
LEWANDER T
HACKSELL U
Citation: Y. Liu et al., DERIVATIVES OF CIS-2-AMINO-8-HYDROXY-1-METHYLTETRALIN - MIXED 5-HT(1A)-RECEPTOR AGONISTS AND DOPAMINE D-2-RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 38(1), 1995, pp. 150-160
Authors:
JACKSON DM
MOHELL N
BENGTSSON A
MALMBERG A
Citation: Dm. Jackson et al., WHY DOES CLOZAPINE STIMULATE THE MOTOR-ACTIVITY OF RESERPINE-PRETREATED RATS WHEN COMBINED WITH A DOPAMINE D-1 RECEPTOR AGONIST, European journal of pharmacology, 282(1-3), 1995, pp. 137-144
Authors:
MALMBERG A
NORDVALL G
JOHANSSON AM
MOHELL N
HACKSELL U
Citation: A. Malmberg et al., MOLECULAR-BASIS FOR THE BINDING OF 2-AMINOTETRALINS TO HUMAN DOPAMINED-2A AND D-3 RECEPTORS, Molecular pharmacology, 46(2), 1994, pp. 299-312
Authors:
OHLSON KBE
MOHELL N
CANNON B
LINDAHL SGE
NEDERGAARD J
Citation: Kbe. Ohlson et al., THERMOGENESIS IN BROWN ADIPOCYTES IN INHIBITED BY VOLATILE ANESTHETICAGENTS - A FACTOR CONTRIBUTING TO HYPOTHERMIA IN INFANTS, Anesthesiology, 81(1), 1994, pp. 176-183
Citation: Dm. Jackson et al., PRECLINICAL FINDINGS WITH NEW ANTIPSYCHOTIC AGENTS - WHAT MAKES THEM ATYPICAL, Acta psychiatrica Scandinavica, 89, 1994, pp. 41-48
Authors:
MALMBERG A
NORDVALL G
JOHANSSON AM
MOHELL N
HACKSELL U
Citation: A. Malmberg et al., THE INTERACTION OF 2-AMINOTETRALINS WITH DOPAMINE D(2) AND D(3) RECEPTORS, Neuropsychopharmacology, 9(2), 1993, pp. 190000160-190000160
Authors:
MALMBERG A
JACKSON DM
ERIKSSON A
MOHELL N
Citation: A. Malmberg et al., UNIQUE BINDING CHARACTERISTICS OF ANTIPSYCHOTIC AGENTS INTERACTING WITH HUMAN DOPAMINE D(2A), D(2B), AND D(3) RECEPTORS, Molecular pharmacology, 43(5), 1993, pp. 749-754
Authors:
MOHELL N
SALLEMARK M
ROSQVIST S
MALMBERG A
HOGBERG T
JACKSON DM
Citation: N. Mohell et al., BINDING CHARACTERISTICS OF REMOXIPRIDE AND ITS METABOLITES TO DOPAMINE-D2 AND DOPAMINE-D3 RECEPTORS, European journal of pharmacology, 238(1), 1993, pp. 121-125
Authors:
UNELIUS L
BRONNIKOV G
MOHELL N
NEDERGAARD J
Citation: L. Unelius et al., PHYSIOLOGICAL DESENSITIZATION OF BETA(3)-ADRENERGIC RESPONSES IN BROWN FAT-CELLS - INVOLVEMENT OF A POSTRECEPTOR PROCESS, The American journal of physiology, 265(5), 1993, pp. 30001340-30001348